236 related articles for article (PubMed ID: 22832488)
1. CYLD inhibits melanoma growth and progression through suppression of the JNK/AP-1 and β1-integrin signaling pathways.
Ke H; Augustine CK; Gandham VD; Jin JY; Tyler DS; Akiyama SK; Hall RP; Zhang JY
J Invest Dermatol; 2013 Jan; 133(1):221-9. PubMed ID: 22832488
[TBL] [Abstract][Full Text] [Related]
2. CYLD inhibits tumorigenesis and metastasis by blocking JNK/AP1 signaling at multiple levels.
Miliani de Marval P; Lutfeali S; Jin JY; Leshin B; Selim MA; Zhang JY
Cancer Prev Res (Phila); 2011 Jun; 4(6):851-9. PubMed ID: 21478324
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of CYLD expression by Snail promotes tumor progression in malignant melanoma.
Massoumi R; Kuphal S; Hellerbrand C; Haas B; Wild P; Spruss T; Pfeifer A; Fässler R; Bosserhoff AK
J Exp Med; 2009 Jan; 206(1):221-32. PubMed ID: 19124656
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of cylindromatosis gene, CYLD, confers a growth advantage on malignant melanoma cells while negatively regulating their migration activity.
Ishikawa Y; Tsunoda K; Shibazaki M; Takahashi K; Akasaka T; Masuda T; Maesawa C
Int J Oncol; 2012 Jul; 41(1):53-60. PubMed ID: 22469839
[TBL] [Abstract][Full Text] [Related]
5. Negative regulation of JNK signaling by the tumor suppressor CYLD.
Reiley W; Zhang M; Sun SC
J Biol Chem; 2004 Dec; 279(53):55161-7. PubMed ID: 15496400
[TBL] [Abstract][Full Text] [Related]
6. FRA1 promotes squamous cell carcinoma growth and metastasis through distinct AKT and c-Jun dependent mechanisms.
Zhang X; Wu J; Luo S; Lechler T; Zhang JY
Oncotarget; 2016 Jun; 7(23):34371-83. PubMed ID: 27144339
[TBL] [Abstract][Full Text] [Related]
7. Notch1 signaling promotes primary melanoma progression by activating mitogen-activated protein kinase/phosphatidylinositol 3-kinase-Akt pathways and up-regulating N-cadherin expression.
Liu ZJ; Xiao M; Balint K; Smalley KS; Brafford P; Qiu R; Pinnix CC; Li X; Herlyn M
Cancer Res; 2006 Apr; 66(8):4182-90. PubMed ID: 16618740
[TBL] [Abstract][Full Text] [Related]
8. Adhesion control of cyclin D1 and p27Kip1 levels is deregulated in melanoma cells through BRAF-MEK-ERK signaling.
Bhatt KV; Spofford LS; Aram G; McMullen M; Pumiglia K; Aplin AE
Oncogene; 2005 May; 24(21):3459-71. PubMed ID: 15735667
[TBL] [Abstract][Full Text] [Related]
9. KLF6 Gene and early melanoma development in a collagen I-rich extracellular environment.
Huh SJ; Chen YL; Friedman SL; Liao J; Huang HJ; Cavenee WK; Robertson GP
J Natl Cancer Inst; 2010 Aug; 102(15):1131-47. PubMed ID: 20660366
[TBL] [Abstract][Full Text] [Related]
10. CYLD Inhibits the Development of Skin Squamous Cell Tumors in Immunocompetent Mice.
Alameda JP; García-García VA; López S; Hernando A; Page A; Navarro M; Moreno-Maldonado R; Paramio JM; Ramírez Á; García-Fernández RA; Casanova ML
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34201751
[TBL] [Abstract][Full Text] [Related]
11. CYLD controls c-MYC expression through the JNK-dependent signaling pathway in hepatocellular carcinoma.
Pannem RR; Dorn C; Ahlqvist K; Bosserhoff AK; Hellerbrand C; Massoumi R
Carcinogenesis; 2014 Feb; 35(2):461-8. PubMed ID: 24104553
[TBL] [Abstract][Full Text] [Related]
12. C-Jun drives melanoma progression in PTEN wild type melanoma cells.
Kappelmann-Fenzl M; Gebhard C; Matthies AO; Kuphal S; Rehli M; Bosserhoff AK
Cell Death Dis; 2019 Aug; 10(8):584. PubMed ID: 31378787
[TBL] [Abstract][Full Text] [Related]
13. lncRNA-MEG3 Suppresses the Proliferation and Invasion of Melanoma by Regulating CYLD Expression Mediated by Sponging miR-499-5p.
Long J; Pi X
Biomed Res Int; 2018; 2018():2086564. PubMed ID: 29808164
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of activating transcription factor-2 is required for tumor growth and progression in mouse skin tumors.
Papassava P; Gorgoulis VG; Papaevangeliou D; Vlahopoulos S; van Dam H; Zoumpourlis V
Cancer Res; 2004 Dec; 64(23):8573-84. PubMed ID: 15574764
[TBL] [Abstract][Full Text] [Related]
15. CYLD negatively regulates cell-cycle progression by inactivating HDAC6 and increasing the levels of acetylated tubulin.
Wickström SA; Masoumi KC; Khochbin S; Fässler R; Massoumi R
EMBO J; 2010 Jan; 29(1):131-44. PubMed ID: 19893491
[TBL] [Abstract][Full Text] [Related]
16. P21-activated protein kinase (PAK2)-mediated c-Jun phosphorylation at 5 threonine sites promotes cell transformation.
Li T; Zhang J; Zhu F; Wen W; Zykova T; Li X; Liu K; Peng C; Ma W; Shi G; Dong Z; Bode AM; Dong Z
Carcinogenesis; 2011 May; 32(5):659-66. PubMed ID: 21177766
[TBL] [Abstract][Full Text] [Related]
17. Interplay between TAp73 Protein and Selected Activator Protein-1 (AP-1) Family Members Promotes AP-1 Target Gene Activation and Cellular Growth.
Subramanian D; Bunjobpol W; Sabapathy K
J Biol Chem; 2015 Jul; 290(30):18636-49. PubMed ID: 26018080
[TBL] [Abstract][Full Text] [Related]
18. Cell cycle arrest and apoptosis of melanoma cells by docosahexaenoic acid: association with decreased pRb phosphorylation.
Albino AP; Juan G; Traganos F; Reinhart L; Connolly J; Rose DP; Darzynkiewicz Z
Cancer Res; 2000 Aug; 60(15):4139-45. PubMed ID: 10945621
[TBL] [Abstract][Full Text] [Related]
19. A pro-inflammatory role of deubiquitinating enzyme cylindromatosis (CYLD) in vascular smooth muscle cells.
Liu S; Lv J; Han L; Ichikawa T; Wang W; Li S; Wang XL; Tang D; Cui T
Biochem Biophys Res Commun; 2012 Mar; 420(1):78-83. PubMed ID: 22406061
[TBL] [Abstract][Full Text] [Related]
20. Dual c-Jun N-terminal kinase-cyclin D1 and extracellular signal-related kinase-c-Jun disjunction in human melanoma.
Pathria G; Garg B; Garg K; Wagner C; Wagner SN
Br J Dermatol; 2016 Dec; 175(6):1221-1231. PubMed ID: 27145925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
